Both the pathogenesis and etiology of Alzheimer's disease are unknown. Severity of the disease is correlate with deficits of cholinergic functions in the cortex and hippocampus accompanied by the loss of cholinergic neurons in the basal forebrain which innervate these regions. This neuronal loss may be a consequence of changes in biochemical signals coming from the cells which these neurons innervate of from surrounding non-neuronal cells. The long-term objective of this research is to identify endogenous compounds in the brain which can enhance the survival, growth and differentiation of cholinergic neurons in the basal forebrain, to characterize their modes of action and to establish their physiological relevance. Such information may help to elucidate the etiology of the cholinergic deficit in Alzheimer's disease and lead to the development of a useful therapy. Our studies have already led to the finding that phosphoethanol-amine can enhance the synthesis of acetylcholine forebrain cholinergic neurons.
The specific aims of this project are as follows: (1) to determine the specificity of action of phosphoethanolamine on different neuronal populations by examining its in vitro effects on neurotransmitter synthesis and uptake in cholinergic, dopaminergic and GABAergic neurons: (2) to determine if phosphoethanolamine enhances acetylcholine synthesis by influencing the survival of cholinergic neurons, or by modulating the transport and metabolism of choline: (3) to determine if phosphoethanolamine can increase the in vivo synthesis and release of acetylcholine in aged rat brains and in lesioned adult brains which have received embryonic transplants.
Specific aim (1) and (2) will be addressed by measuring biochemical changes in neurotransmitter enzyme activities , uptake processes, and the synthesis and release of neurotransmitter in cultured cells and tissue preparations. Immunohistochemical techniques will also be employed to monitor survival effects.
Specific aim (3) will be investigated by infusing phosphoethanolamine into rat brains and measuring subsequent effects on acetylcholine synthesis and release by in vivo brain microdialysis or by biochemical and histochemical measurements on brain slices.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008664-03
Application #
3802780
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Doody, R; Pavlik, V; Massman, Paul et al. (2005) Changing patient characteristics and survival experience in an Alzheimer's center patient cohort. Dement Geriatr Cogn Disord 20:198-208
Waring, Stephen C; Doody, Rachelle S; Pavlik, Valory N et al. (2005) Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord 19:178-83
Hoyt, Brian D; Massman, Paul J; Schatschneider, Christopher et al. (2005) Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Arch Neurol 62:454-9
Snow, A Lynn; Norris, Margaret P; Doody, Rachelle et al. (2004) Dementia Deficits Scale. Rating self-awareness of deficits. Alzheimer Dis Assoc Disord 18:22-31
Doody, Rachelle Smith; Dunn, J Kay; Huang, Eugene et al. (2004) A method for estimating duration of illness in Alzheimer's disease. Dement Geriatr Cogn Disord 17:1-4
Atchison, Timothy B; Bradshaw, Major; Massman, Paul J (2004) Investigation of profile difference between Alzheimer's disease patients declining at different rates: examination of baseline neuropsychological data. Arch Clin Neuropsychol 19:1007-15
Graham, David P; Cully, Jeffrey A; Snow, A Lynn et al. (2004) The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls. Alzheimer Dis Assoc Disord 18:236-40
Clark, Christopher M; Xie, Sharon; Chittams, Jesse et al. (2003) Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60:1696-702
Davis, Robert N; Massman, Paul J; Doody, Rachelle S (2003) WAIS-R factor structure in Alzheimer's disease patients: a comparison of alternative models and an assessment of their generalizability. Psychol Aging 18:836-43
Davis, Robert N; Massman, Paul J; Doody, Rachelle S (2003) Effects of blood pressure on neuropsychological functioning in Alzheimer's disease. Arch Clin Neuropsychol 18:19-32

Showing the most recent 10 out of 48 publications